| Literature DB >> 35337316 |
José Rodrigo M Andrade1, Luciano Costa Blomberg2.
Abstract
BACKGROUND: The management of the use of iodinated contrast agents (ICA) in the computed tomography (CT) has clinical and financial impacts; however, the approaches in the current research setting have limitations with regard to their exploration of the theme. This work describes the application of the stages of a process of business intelligence (BI), from the formulation of business questions, the building of a research database, and the adaptation of a multidimensional model, to the creation of dashboards to give support to the decision-making process in a hospital. This research aims to apply and document a BI process that provides support to the decision making of managers, so the use of ICA can be better managed, allowing for the identification of situations in which the material was wasted using a study applied to the hospital field.Entities:
Keywords: Business intelligence; Contrast media; Diagnostic imaging; Radiology
Mesh:
Substances:
Year: 2022 PMID: 35337316 PMCID: PMC8957133 DOI: 10.1186/s12911-022-01814-9
Source DB: PubMed Journal: BMC Med Inform Decis Mak ISSN: 1472-6947 Impact factor: 2.796
Fig. 1BI process applied in the HCPA (figure created by the authors)
Fig. 2Form of existence of the variables in the Qdoc system: native and created
Fig. 3Form of input of variables in the Qdoc system: automatic or manual input
Set of variables used in the multidimensional request-procedure model with a description of the variable and of its type of existence in the model
| Set | Variable ID | Name of the variable | Description of the variable | Type of existence in the model |
|---|---|---|---|---|
| 1st quadrant: Native and created variables of interest generated by the transaction system and imported into the model | 1 | Date | Date in which the patient was cared for | NM |
| 2 | Time | Time in which the attention took place | NM | |
| 3 | Age (years) | Age of the patient at the day of the attention | NM | |
| 4 | Sex | Sex of the patient | NM | |
| 5 | Patient mass | Mass of the patient at the day of the attention | CP | |
| 6 | Name of the exam | Name of the exam | NM | |
| 7 | Part of the body | Part of the body analyzed | NM | |
| 8 | Modality | Diagnostic modality (CT scan, magnetic resonance imaging, X-ray, ultrasound scan, etc.) | NM | |
| 9 | Origin of attention | Classification of the origin of the attention (outpatient clinic, hospitalization, emergency, external) | NM | |
| 10 | Clinical information | Information described by the physician requesting the exam, together with the request and including relevant information on the clinical issues of the patient and the reason why the exam was requested. It accompanies a set of answers to questions of interest of the radiologist, which aim to aid in the medical diagnostic | NM | |
| 11 | Exam room | Room in which the exam was conducted (room 1, room 2, room 3, all rooms) | NM | |
| 12 | ICA concentration (mg iodine/mL) | ICA concentration (300 mg iodine/mL, 350 mg iodine/mL, all concentrations) | CO | |
| 13 | Batch number | Number of the batch of the ICA | CO | |
| 14 | Form of ICA injection | Manner in which the ICA was injected (automated with an injector pump, manual with a syringe, all manners) | CO | |
| 15 | Injection flow of ICA (mL/s) | Injection flow of the ICA through an endovenous pathway | CO | |
| 16 | Occurrence of adverse reactions | Occurrence of adverse reactions | CO | |
| 17 | Occurrence of extravasation | Occurrence of extravasation | CO | |
| 18 | Amount of extravasation | Amount of extravasation | CO | |
| 19 | Pacient_code | Sequential number of the attention within the RIS system | NM | |
| 20 | Request_code | Sequential number in the HIS system of exam requests | NM | |
| 21 | Exam_code | Identification code of the exam | NM | |
| 22 | Radiology Technician_code | Identification code of the Radiology technician | NM | |
| 23 | Nursing Technician_code | Identification code of the Nursing technician | NM | |
| 24 | ICA volume (mL) | Records of the volume of ICA injected in the patient | CO | |
| 2nd quadrant: complementary variables of interest that already existed in the model | 25 | Year | Year in which attention took place | EM |
| 26 | Month | Name of the month in which attention took place | EM | |
| 27 | Day | Number of the day in which the attention took place | EM | |
| 28 | Weekday | Weekday in which the attention took place | EM | |
| 29 | Semester | Name of the semester in which attention took place | EM | |
| 30 | Trimester | Name of the trimester in which attention took place | EM | |
| 31 | Hour | Hour in which the attention took place | EM | |
| 32 | Equipment | Equipment used to carry out the exam, including a description of the producer and number of channels (Ge 8 channels, Phillips—16 channels, Toshiba—64 channels, all) | EM | |
| 33 | Name of the Radiology technician | Name of the Radiology technician that carried out the attention | EM | |
| 34 | Name of the Nursing technician | Name of the Nursing technician that carried out the attention | EM | |
| 35 | No. of exams | Measure—sum of exams | EM | |
| 3rd quadrant: secondary variables and measurements calculated and created in the model | 36 | Shift | Work shift (morning – 7:00 a.m. to 12:59 p.m, afternoon – 1:00 p.m. to 6:59 p.m, Night – 7:00 p.m to 6:59 a.m., all) | CM |
| 37 | Age group | Age group of the patient at the day of the attention | CM | |
| 38 | Mass range | Mass range of the patient at the day of the attention | CM | |
| 39 | Specialty | Medical specialty of radiological diagnostic | CM | |
| 40 | Exam group | Group of the exam (tomography or angiotomography) | CM | |
| 41 | Cost (R$/mL) | Ratio of financial value to ICA volume | MC | |
| 42 | Volume per mass (mL/Kg) | Ratio of the volume of ICA injected in the patient to the mass of the patient | MC | |
| 43 | Reference values for volume (mL) | Reference values for the volume of ICA to be injected for each combination of exam and weight range of the patient | MC | |
| 44 | Excess (mL) | Volume of ICA injected above the volume limit | MC | |
| 45 | Cost of the excess (R$) | Cost of the volume of ICA injected above the volume limit | MC | |
| 46 | Rate of contrasted patients (%) | Rate of variable 47 to variable 35 | MC | |
| 47 | No. of contrasted exams | Sum of the exams where variable 12 was filled in | MC | |
| 48 | Maximum volume per exam (mL/exam) | Ratio of the sum of the volume of ICA injected in the patient to the sum of the exams carried out | MC |
Captions: Acronyms correspond to the form of existence in the multidimensional request-procedure model: NM—native Qdoc variable that previously existed in the model; CO—variable created in the Qdoc and imported into the model by request of the organization; CP—variable created at the Qdoc and imported to into the model at the request of the researchers; EM—variable that already existed in the model; CM—secondary variable created in the model by the researchers; MC—measure calculated and created in the model by the researchers
Fig. 4Proposal of an investigative dashboard to answer to the business question using OLAP operations with an example of an analysis from four perspectives
Analysis of the data cube from six perspectives
| Perspectives | Selection options |
|---|---|
| When? | Year: 2017, 2018, 2019, ou all Semester: 1st, 2nd, or all Trimester: 1st, 2nd, 3rd, 4th, or all Month: free choice of month, or all Work shift: morning (7:00 a.m. to 12:59 p.m), afternoon (1:00 p.m. to 6:59 p.m), night (7:00 p.m to 6:59 a.m.), or all) |
| Where | Room 1, equipped with the 8-channel Ge CT, Room 2, equipped with the 16-channel Philips CT, Room 3, equipped with the 64-channel Toshiba CT, or all rooms |
| Which? | Individual choice of the code of the exam, or all exam codes |
| What? | ICA, in a 300 mg Iodine/mL concentration, ICA, in a 350 mg Iodine/mL concentration, or all concentrations |
| How? | automated ICA injection using an injection pump, manual ICA injection, or all injections |
| Who? | Individual choice using the code of the radiology technician, or all radiology technicians |
Fig. 5Ratio of ICA volume injected to patient mass in the HCPA Radiology Service in June 2018, with highlights on the quadrant of undesirable situations
Fig. 6Ratio of ICA volume injected to patient mass in the HCPA Radiology Service in June 2018, by Radiology technician A
Fig. 7Ratio of ICA volume injected to patient mass in the HCPA Radiology Service in June 2018, by Radiology technician B
Support to decision making in the choice of the pilot exam, using the Pareto chart and considering the data cube
| Questions of interest of the managers for decision making, about where to start | Code of the exam | Sum (%) | |||
|---|---|---|---|---|---|
| TCAB1 (%) | TCTX1 (%) | TCCR1 (%) | OUTROS (%) | ||
| 1. Among exams that use the ICA, which one happens the most? | 39 | 25 | 7 | 29 | 100 |
| 2. Among exams that use the ICA in a 300 mg iodine/mL, which one happens the most? | 47 | 31 | 7 | 15 | 100 |
| 3. Among exams that use the ICA, which one uses the most volume of the material? | 42 | 26 | 5 | 27 | 100 |
| 4. Among exams that use the ICA, which one uses the most volume of the material in a 300 mg iodine/mL concentration? | 50 | 31 | 5 | 14 | 100 |
TCAB1 (full CT scan of the abdomen), TCTX1 (CT scan of the thorax), and TCCR1 (CT scan of the skull/brain)
Protocol of ICA injection for TCAB1 exams containing the volume of reference according to mass range and concentration
| Mass range of the patient | 300 mg iodine/mL | 350 mg iodine/mL |
|---|---|---|
| Up to 45 kg | 54 mL | 45 mL |
| From 46 to 55 kg | 70 mL | 50 mL |
| From 56 to 65 kg | 80 mL | 60 mL |
| From 66 to 80 kg | 90 mL | 75 mL |
| From 81 to 95 kg | 100 mL | 90 mL |
| More than 96 kg | 110 mL | 100 mL |
Fig. 8Comparison of data in the periods A and B, respectively corresponding to the scenarios before and after the ICA injection protocol for TCAB1 exams was changed
Fig. 9Comparison of the data about the volume of ICA per patient mass range for the TCAB1 exam using ICA in a 300 mg iodine/mL concentration
Assessment of the financial impacts for TCAB1 exams
| Information about the measurement | 07/01/2017 to 06/30/2018 | 07/01/2018 to 06/30/2019 | Annual mean | Sum |
|---|---|---|---|---|
| Total volume used | 719,898 mL | 705,699 mL | 712,799 mL | 1,425,597 mL |
| Volume that could have been used considering the new ICA injection protocol | 602,638 mL | 599,850 mL | 601,244 mL | 1,202,488 mL |
| Excessive volume used | 117,260 mL | 105,849 mL | 111,555 mL | 223,109 mL |
| Value of the excess | US$ 10,553.40 | US$ 9,526.41 | US$ 10,039.95 | US$ 20,079.81 |
The value used to calculate the projection is based on the last public notice in the electronic bidding model carried out by the HCPA to acquire ICA. The cost of each mL of 300 mg iodine/mL concentration ICA is of US$ 0.09
Fig. 10Descreptive analyses
Impact and relevance in the perception of the managers about the BI process as applied in the HCPA
| BI process applied in the HCPA | Mean percentage of the impact and relevance in the perception of the managers (%) |
|---|---|
| Was the result presented satisfactory? | 100 |
| Was it important to identify the waste of ICA? | 100 |
| Was it important to give support to the decision making process? | 96 |
| Did it help in the planning of actions and in the definition of controls from the evidence generated? | 100 |
| Did it help in the control of undesirable situations? | 100 |
| - ICA injections with values above 2 mL/kg | |
| - Injections above the reference value indicated in the ICA injection protocol for the TCAB1 exam | |
| Did it enable a better management of ICA use? | 100 |
| Did it generate a satisfactory financial result? | 100 |
| Did it generate benefits for the patients? | 100 |
| Was it decisive for the follow up of operational routines? | 100 |
| Should it continue to be used? | 100 |